The trial is designed to assess the therapy's efficacy when administered subcutaneously in single ascending doses.

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2. All three cohorts show separation from placebo ...

Anti-OX40 medications have been associated with positive efficacy and safety outcomes for the treatment of atopic dermatitis.

Investors were surely discovering drug discovery company AbCellera Biologics ( ABCL 6.19%) as the trading week kicked off on ...

Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time ...

Investigating allergy prevention, this research highlights early intervention strategies and the promise of biologic ...

Sun Pharma has discontinued the development of SCD-044 after Phase 2 trials failed to meet primary goals in treating ...

Sun Pharma’s experimental drug SCD-044 did not meet its main goals in Phase 2 trials for psoriasis and atopic dermatitis. The ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the discontinuation of two clinical trials evaluating SCD-044, a ...